OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Japan Approves Bayer’s Sevabertinib for HER2-Mutant NSCLC Across All Lines of Therapy

Fabio Moraes: Can We Trust AI in Radiation Oncology? A Practical Perspective

10 Must-Read Posts In GI Oncology This Week

Do Energy Drinks Cause Cancer? Myths, Facts, and What Science Really Shows

EANO Consensus Statement Guides Diagnosis and Management of Radiation Necrosis

Oncology News, Insights, Stories by OncoDaily

FDA
Societies

FDA Published 55 Product-Specific Guidances to Accelerate Generic Drug Development

Erasca
Public Health

Erasca Receives FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Metastatic Pancreatic Cancer

Dato-DXd
Lung Oncology

Dato-DXd in Lung Cancer: International Experts Define New Strategies to Manage ADC Toxicities

Multiple Myeloma in 2026: Comprehensive Clinical Update

Douglas Flora: Making Mental Health Part of Cancer Care

Pavlos Msaouel: New Therapeutic Insights in Renal Medullary Carcinoma

Lacy Hubbard: 5 African Nations Unite With the Elekta Foundation to Eliminate Cervical Cancer

Karen Knudsen’s Exclusive Commentary on the New Moderna Cancer Vaccine

Hesham ElGhazaly: Building Egypt’s Next Generation of Liver Cancer Research

Lung Cancer Immunotherapy: Real-World Survival and Costs in France

Voices
Matthew Kurian

Matthew Kurian: What Internists and Clinicians Need to Know About the Latest in Breast Cancer Care

Michael Hofman: There is Still Time to Join Us in Melbourne for ProsTIC26

Mel Mann: The Treatments We Have Today Exist Because Patients Before Us Said Yes to Research

Al-Ola A Abdallah: Proud of the Remarkable Team Behind 10 Years of Myeloma Care

Impressive Results from ITCC-059 Trial of Inotuzumab Ozogamicin - Princess Máxima Center

Stephen Oh: Grateful for the Opportunity to Share Our Work at the Carolinas MPN Workshop

Mark Yarchoan: The Era of Non-Specific Checkpoint Intensification is Finally Coming to a Close

FDA Approvals
OncoSil

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

OncoDaily 100
100 Influential People in Oncology

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Celebrities and Cancer

OncoCalendar

Advancing Surgical Oncology in the Era of Multidisciplinary Cancer Care

Memorial Sloan Kettering Cancer Center (MSK)

28 Oct
Advancing Surgical Oncology

2026 Accelerated Review in Medical Oncology

Memorial Sloan Kettering Cancer Center (MSK)

23 Oct
Accelerated Review in Medical Oncology

2026 Advances in Prostate Cancer Management: A Multidisciplinary Approach

Memorial Sloan Kettering Cancer Center (MSK)

08 Oct
Advances in Prostate Cancer

Transforming Pediatric and Young Adult Brain and Spine Tumor Care Through Multidisciplinary Innovation

Memorial Sloan Kettering Cancer Center (MSK)

02 Oct
Brain and Spine Tumor

TxSCO 2026 Annual Conference

Texas Society of Clinical Oncology (TxSCO)

18 Sep
TxSCO 2026

Immune-oncology
5 Must-Read Posts About CAR-T This Week

5 Must-Read Posts About CAR-T This Week

Lung Cancer Immunotherapy: Real-World Survival and Costs in France

INTerpath-001 Trial: Personalized mRNA Cancer Vaccine for Melanoma

Tumor Mutational Burden in Immunotherapy: Why TMB Is More Than a Number

CheckMate 77T study: Can ctDNA Predict Response to Perioperative Immunotherapy in NSCLC?

PIVOTAL Trial: Neoadjuvant Intralesional Immunotherapy in Melanoma

Hypoxia and Immunotherapy Resistance: Can HIF Targeting Improve Response?

Gastrointestinal-Oncology
GI Oncology

10 Must-Read Posts In GI Oncology This Week

ctDNA Identifies High Recurrence Risk After Resection of Stage I–III Biliary Tract Cancer

Comprehensive Genomic Profiling in GI Oncology: Real-World Impact and Challenges

ESMO Clinical Practice Guideline Express Update: Daraxonrasib for Metastatic Pancreatic Cancer

GI Cancers Alliance: Could Cancer Vaccines Change the Future of Lynch Syndrome and GI Cancers?

FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma

PLATFORM: Maintenance Rucaparib in Advanced HER2-Negative Esophagogastric Adenocarcinoma

Breast-Oncology
Oncotype DX

Oncotype DX-Guided Chemotherapy Associated With Improved Survival in HR+/HER2− Breast Cancer

Insights From I-SPY2 Trial: Dual Immune Checkpoint Blockade Shows Promise in High-Risk ERBB2-Negative Early Breast Cancer

TQB2102 and the Evolution of HER2 Antibody-Drug Conjugates: Exploring the Role of Payload Optimisation in Breast Cancer

HER2DX Predicts Pathologic Complete Response in HER2-Positive Breast Cancer After Neoadjuvant THP

Neo-CheckRay: iSBRT and Durvalumab in High-Risk ER+/HER2− Breast Cancer

HER2DX in Early HER2-Positive Breast Cancer: Toward Biology-Guided Treatment Intensity

Breast Cancer in 2026: Molecular Interception, MRD, ADC Sequencing and De-Escalation

Lung-Oncology
Dato-DXd

Dato-DXd in Lung Cancer: International Experts Define New Strategies to Manage ADC Toxicities

Lung Cancer Screening in Women: 5 Breakthrough Insights Highlight New Risk Groups

MET Exon 14 Skipping NSCLC: DECIDE-MET Trial Addresses a Critical Question in First-Line Treatment Selection

KEYNOTE-671: Five-Year Data Confirm Durable Benefit of Perioperative Pembrolizumab in Early-Stage NSCLC

RAS-Mediated Resistance Emerges Across Oncogene-Driven NSCLC

CheckMate 77T: ctDNA Clearance and MRD Refine Risk After Perioperative Nivolumab

DESTINY-Lung04: Enhertu Improves First-Line PFS in HER2-Mutant NSCLC

Oncology Tech
Anthropic's AI Protein Design Run: 354 Binders, 15 Targets

Anthropic's AI Protein Design Run: 354 Binders, 15 Targets

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

AstraZeneca-Bristol Myers Merger Denied: What It Exposed

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

Hematology
Multiple Myeloma (MM) SMM

Multiple Myeloma in 2026: Comprehensive Clinical Update

Central Nervous System (CNS) Lymphoma: Reaching the Tumor Across CNS Barriers

VEXAS Syndrome: Is It More a Matter of Inflammation or Hematopoietic Clonality?

Venetoclax + HMA in Newly Diagnosed AML: What Do Real-World Data Show?

BeOne, BeOne Care Foundation and The Max Foundation Renew BRUKINSA Access Partnership for CLL in LMICs

TP53-Mutated MDS: Can New Therapies Change the Prognosis?

Novel Combinations in Myelofibrosis: Advancing Beyond the JAK Inhibitor Backbone

Radiotherapy
Radionecrosis

EANO Consensus Statement Guides Diagnosis and Management of Radiation Necrosis

Neoadjuvant SBRT and Immunotherapy Show Potential in High-Risk ER+/HER2− Breast Cancer

Call for Papers: “Radiation Oncology in 2026” Special Series

10 Must-Read Posts In Radiotherapy This Week: August 10-16

Mayo Clinic Reports First Clinical Series of Minibeam Radiation Therapy for Superficial Malignancies

TREASURE Trial Raises Safety Concerns Over Thoracic Radiotherapy in ES-SCLC

ESTRO Breast Radiotherapy Target Volumes Prospectively Validated in DBCG Skagen Trial 1

OncoDaily TV
Maggie Smith breast cancer

Dame Maggie Smith and Courageus Breast Cancer Journey: Filming Harry Potter During Chemotherapy

Petra Jankowska

Leading with Humanity in Modern Oncology: Dr. Petra Jankowska

Princess Dina

Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah

Empowering Oncologist

Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll

Dr. C.S. Pramesh

The Power of Collaboration in Fighting Cancer: Dr. C.S. Pramesh

Tommy Bramley

Making Innovative Oncology Therapies Accessable for All Patients: Tommy Bramley

Rolando Camacho

Beyond the Policy Paper: Turning Cancer Plans into Real Impact: Dr. Rolando Camacho

Nirmala Bhoo-Pathy

Nirmala Bhoo-Pathy: How to Translate Scientific Breakthroughs into Real-world Benefits

The Man Who Built Elekta: Larry Leksell

The Man Who Built Elekta: Larry Leksell

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Not To Miss
AAADV

AAADV Leaders on the Shifting Landscape of Global Cancer Drug Development

FDA Grants Priority Review to GSK’s Jemperli for dMMR/MSI-H Locally Advanced Rectal Cancer

European Commission has Granted Marketing Authorization for Gilead Sciences’ Trodelvy Plus Keytruda for First-Line PD-L1-Positive Metastatic TNBC

Japan Approves Bayer’s Sevabertinib for HER2-Mutant NSCLC Across All Lines of Therapy

Jill Biden Shares Update on Joe Biden’s Latest Cancer Scans

Noubar Afeyan on Moderna and Merck’s Phase 3 INTerpath-001 Results: “It Was a Déjà Vu Moment”

AAADV 2026: Where the Future of Cancer Drug Development Will Be Debated

OncoGrants
Prostate Cancer UK Internship Programme

Windsor Fellowship–Prostate Cancer UK Internship Programme 2026/27

Bio-Resource Coordinating Hub

CIHR Team Grant for National Cancer Data and Bio-Resource Coordinating Hub 2026–2027

Brain Cancer Research Grant

MRFF Australian Brain Cancer Mission – 2026 Brain Cancer Research Grant

Oncology and Hematology Community Grants

Gilead/Kite Canada’s Oncology and Hematology Community Grants Program

Breath Research Award

Lung Cancer Canada Give a Breath Research Award 2026 for Advanced Lung Cancer

Award in Digestive Cancer

AGA-Caroline Craig Augustyn and Damian Augustyn Award in Digestive Cancer 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Khushali Jhaveri

Khushali Jhaveri

Oncologists Location Indianapolis, USA
Teena Nelson

Teena Nelson

Oncologists Location Thiruvananthapuram, India
Mary Gospodarowicz

Mary Gospodarowicz

Oncologists Location Toronto, Canada
Alexandra Müller

Alexandra Müller

Oncologists Location Freiburg, Germany
Shui Yen Soh

Shui Yen Soh

Oncologists Location Singapore, Singapore
Sandy Carmona Lozano

Sandy Carmona Lozano

Oncologists Location Pueblo Libre, Peru
Francesco Massari

Francesco Massari

Oncologists Location Bologna, Italy
Nermean Mostafa

Nermean Mostafa

Oncologists Location Cairo, Egypt

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Al-Ola Abdallah

Al-Ola A Abdallah: What Did We Learn From the CANOVA Phase III Trial?

Miguel Bronchud

Miguel Bronchud: Does More Drugs Mean Better Outcomes in dMMR Colorectal Cancer?

Felipe Couñago

Felipe Couñago: Rethinking Pelvic Irradiation in High-Risk Prostate Cancer

Pavlos Msaouel

Pavlos Msaouel: New Therapeutic Insights in Renal Medullary Carcinoma

Carmen Saiz Guisasola

Carmen Saiz Guisasola: Dose-Escalated TNT Shows Promise in Rectal Cancer

Walid Kamoun

Walid Kamoun Highlights Next-Generation In Vivo Antibody–ADC Click Technology

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-012-0826-7730

Chronic illness trajectory of patients with multiple myeloma derived from health-related quality of life data – an integrative review
Systematic Reviews & Meta Analysis

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries